July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Dark adaptometry and dark-adapted two-color microperimetry in patients with Pseudoxanthoma elasticum
Author Affiliations & Notes
  • Kristina Hess
    Department of Ophthalmology, University of Bonn, Bonn, Germany
  • Martin Gliem
    University of Oxford, Nuffield Laboratory of Ophthalmology, Oxford, United Kingdom
    Department of Ophthalmology, University of Bonn, Bonn, Germany
  • Maximilian Pfau
    Department of Ophthalmology, University of Bonn, Bonn, Germany
  • Philipp L. Mueller
    Department of Ophthalmology, University of Bonn, Bonn, Germany
  • Johannes Birtel
    Department of Ophthalmology, University of Bonn, Bonn, Germany
  • Frank G Holz
    Department of Ophthalmology, University of Bonn, Bonn, Germany
  • Peter Charbel Issa
    University of Oxford, Nuffield Laboratory of Ophthalmology, Oxford, United Kingdom
  • Philipp Herrmann
    Department of Ophthalmology, University of Bonn, Bonn, Germany
  • Footnotes
    Commercial Relationships   Kristina Hess, Carl Zeiss MediTec (F), CenterVue (F), Heidelberg Engineering (F), Optos (F); Martin Gliem, Bayer (R), Carl Zeiss MediTec (F), CenterVue (F), Heidelberg Engineering (F), Heidelberg Engineering (R), Optos (F); Maximilian Pfau, Carl Zeiss MediTec (F), CenterVue (F), Heidelberg Engineering (F), Novartis (R), Optos (F); Philipp Mueller, Carl Zeiss MediTec (F), CenterVue (F), Heidelberg Engineering (F), Optos (F); Johannes Birtel, Carl Zeiss MediTec (F), CenterVue (F), Heidelberg Engineering (F), Optos (F); Frank Holz, Acucela (C), Acucela (F), Allergan (F), Allergan (R), Bayer (C), Bayer (F), Bayer (R), Bioeq (C), Bioeq (F), Boehringer-Ingelheim (C), Carl Zeiss MediTec (R), Carl Zeiss MediTec (F), CenterVue (F), Genentech/Roche (F), Genentech/Roche (R), Graybug Vision (C), Heidelberg Engineering (F), Lin BioScience (C), NightstarX (F), Novartis (F), Optos (F), Oxurion (C), Pixium vision (C), Stealth biosciences (C), Thea (C); Peter Charbel Issa, Heidelberg Engineering (F); Philipp Herrmann, Carl Zeiss MediTec (F), CenterVue (F), Heidelberg Engineering (F), Optos (F)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 5031. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Kristina Hess, Martin Gliem, Maximilian Pfau, Philipp L. Mueller, Johannes Birtel, Frank G Holz, Peter Charbel Issa, Philipp Herrmann; Dark adaptometry and dark-adapted two-color microperimetry in patients with Pseudoxanthoma elasticum. Invest. Ophthalmol. Vis. Sci. 2019;60(9):5031.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To investigate the impact of pathologically altered Bruch’s membrane on dark adaption and low-luminance conditions in patients with Pseudoxanthoma elasticum (PXE).

Methods : Dark adaptation was measured after bleaching (10 minutes, 1600 apostilb) with a 11° stimulus in 35 PXE patients and 35 age-matched controls (Goldmann-Weekers Adaptometer, Haag-Streit, Switzerland). Low luminance deficit and contrast sensitivity were assessed in the same cohorts. In addition, mesopic and dark-adapted two-color (cyan [505 nm] and red [627 nm]) fundus-controlled microperimetry (10-2 test grid, Goldmann III stimuli; S-MAIA, CenterVue; italy) was performed in 20 eyes of 20 PXE patients and compared to age-adjusted normative data in a point-wise manner. The results were analyzed using linear regression and t-tests.

Results : PXE-eyes (age 49.1 ±11.7 years) exhibited an overall prolonged dark adaptation with high interindividual differences compared to controls (52.2 ±12.2 years). The time to adaptation of 4 log Units was significantly longer in PXE-Patients compared with controls (20.1±8.6 vs. 7.7 ±1.3 minutes, p<0.001). Higher low luminance deficit (mean 6.9 ± SD 4.5 ETDRS letters vs. 14.2 ± 7.5 EDTRS letters) and lower contrast sensitivity ((1.31 ±0.36 vs. 1.96 ±0.16 [logUnits]) compared with controls were measured (p<0.001 respectively). On microperimetry, PXE patients exhibited significant dysfunction compared to age-adjusted normative data with average sensitivity losses of -4.79±3.54 dB for mesopic, -3.81± 5.95 dB for dark-adapted cyan and -5.33 ± 4.32 dB for dark-adapted red testing (p<0.001 respectively). Point-wise analysis revealed that that mesopic sensitivity loss was mostly observable for test-points exhibiting dark-adapted cyan sensitivity losses of -14 dB or greater.

Conclusions : The findings indicate that patients with PXE exhibit prolonged dark adaptation kinetics and generally reduced visual function in low ambient light conditions. Impaired permeability of Bruch’s membrane for retinoid cycle intermediates may contribute to these impairmants, while the exact cause currently remains to be determined. Since Bruch’s membrane aging is a pathogenetic factor in age-related macular degeneration (AMD), these findings could add to the understanding of the pathophysiology in AMD.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×